Replies to post #371251 on Anavex Life Sciences Corp (AVXL)

[WolfofMia]

No we didnt because PDD looked at disease specific endpoints, we did get a slam dunk on the part where it correlates to AD by 70-80 percent.

Episodic memory. So yea slam dunk if we can replicated this in AD, along with the other endpoints.

[attilathehunt]

"Well we didn’t get approval in PDD from that ‘slam dunk’ data. Instead we are waiting so far 2 years for another trial."

It's just a big gamble on TGD's part. He is most likely hoping for a basket approval once Excellence results are in...

[Hoskuld]

Wolf didn't say the PD data was slam dunk, he said if the AD P3 results confirm what was signaled in the PD data then that would be slam dunk material.

[Steady_T]

Of course we didn't get approval from a PDD P2 trial for two reasons.
It was a P2 trial.
No NDA gets filed from a P2 trial.

The waiting part is a mystery.